1. Kvasnicka, H. M., Thiele, J., Orazi, A., Horny, H. P. & Bain, B. J. Myeloproliferative neoplasm, unclassifiable. In: S.H. Swerdlow et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 57–59 (IARC Lyon, 2017).
2. Orazi, A., Bennett, J. M., Bain, B. J., Baumann, I., Thiele, J., Bueso-Ramos, C. et al. Myelodysplastic I myeloproliferative neoplasm, unclassifiable. In: S.H. Swerdlow et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 95–96 (IARC: Lyon, 2017).
3. Grinfeld, J., Nangalia, J., Baxter, E. J., Wedge, D. C., Angelopoulos, N., Cantrill, R. et al. Classification and Personalized Prognosis in Myeloproliferative Neoplasms. New England Journal of Medicine379, 1416–1430 (2018).
4. Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P. et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood122, 3616–3627; quiz 3699 (2013).
5. Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R. et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature478, 64–69 (2011).